About this item:

112 Views | 68 Downloads

Author Notes:

Correspondence: Sarah D. Keene, 49 Jesse Hill Jr. Dr. SE, Adanta, GA 30322; skeene@emory.edu

We would like to thank our ECMO team at Children’s Healthcare of Atlanta for their excellent care of these patients and assistance with detailed data collection.

Disclosures: The authors declare that they have no conflicts of interest relevant to the manuscript submitted to TRANSFUSION. Dr. Annie Winkler is an employee at Instrumentation Laboratory but there is no direct relationship to any of the data presented. The findings and conclusions in this abstract are those of the authors and do not necessarily represent the views of the NIH.

Subjects:

Research Funding:

We received no specific financial support for this work

R.M.P. received salary support from the National Heart Lung Blood Institute (NHLBI) under award K23 HL128942 and C.D.J. received support from the NHLBI under award P01 HL086773.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Hematology
  • Cell transfusion
  • RBC Transfusion
  • Thrombocytopenia
  • Recommendations
  • Thresholds
  • Children
  • Impact

Blood product transfusion and mortality in neonatal extracorporeal membrane oxygenation

Tools:

Journal Title:

Transfusion

Volume:

Volume 60, Number 2

Publisher:

, Pages 262-268

Type of Work:

Article | Post-print: After Peer Review

Abstract:

BACKGROUND Neonates receiving extracorporeal membrane oxygenation (ECMO) support are transfused large volumes of red blood cells (RBCs) and platelets (PLTs). Transfusions are often administered in response to specific, but largely unstudied thresholds. The aim of this study is to examine the relationship between RBC and PLT transfusion rates and mortality in neonates receiving ECMO support. STUDY DESIGN AND METHODS We retrospectively examined outcomes of neonates receiving ECMO support in the neonatal intensive care unit (NICU) for respiratory failure between 2010 and 2016 at a single quaternary-referral NICU. We examined the association between RBC and PLT transfusion rate (mL per kg per day) and in-hospital mortality, adjusting for confounding by using a validated composite baseline risk score (Neo-RESCUERS). RESULTS Among the 110 neonates receiving ECMO support, in-hospital mortality was 28%. The median RBC transfusion rate (mL/kg/d) after cannulation was greater among non-survivors, compared to survivors: 12.4 (IQR 9.3–16.2) versus 7.3 (IQR 5.1–10.3), p < 0.001. Similarly, PLT transfusion rate was greater among non-survivors: 22.9 (9.3–16.2) versus 12.1 (8.4–20.1), p = 0.02. After adjusting for baseline mortality risk, both RBC transfusion (adjusted relative risk per 5 mL/kg/d increase: 1.33; 95% Cl 1.05–1.69, p = 0.02) and PLT transfusion (adjusted relative risk per 5 mL/kg/d increase: 1.12; 95% Cl 1.02–1.23, p = 0.02) were both associated with in-hospital mortality. CONCLUSIONS RBC and PLT transfusion rates are associated with in-hospital mortality among neonates receiving ECMO. These data provide a basis for future studies evaluating more restrictive transfusion practices for neonates receiving ECMO support.

Copyright information:

© 2020 John Wiley & Sons, Inc. All rights reserved.

Export to EndNote